University Hospital and New Jersey Medical School (NJMS) are, through their joint FDA-approved convalescent plasma program, collecting plasma donations from patients who have recovered from COVID-19 and infusing it into patients still struggling to fight off the virus. Marc Klapholz, chair of NJMS” Department of Medicine and the hospital’s chief of medical service, explains that the presumed antibodies in the plasma may improve seriously ill patients’ chances for survival. To read the full article.
Recent Posts
- How Beetle Juice Led to the Discovery of a Virus and Solved the Mystery of a Superworm Die-Off.
- Researchers Examine the Persistence of Invisible Plastic Pollution.
- Rutgers Health Officials Celebrate $47.5 Million Grant to Improve Health Care in New Jersey.
- NJACTS Community Engagement Core Available Services
- New Model Identifies Best Candidates for Epilepsy Surgery.
Categories
- Community (2,050)
- Covid (978)
- CTO Events (4)
- News (2,605)
- Pilots (20)